我們邀請了國外學者專家有直播視訊演講(可與外賓溝通討論)也有實體演講，敬邀會員踴躍參加。
請大家按以下連結報名參加，謝謝。
(中華民國血液病學會、台灣內科醫學會、台灣臨床病理檢驗醫學會、臺灣醫事檢驗學會、臺灣兒科醫學會)申請中。
| 時間 | 題目 | 講者 | Moderator |
|---|---|---|---|
| 09:00-09:25 | 會員報到 | ||
| 09:25-09:30 | 開幕致詞 | 彭慶添 理事長 | |
| 專題演講一 | |||
| 09:30-10:15 | (視訊)Living in the new paradigm of Hemophilia B | Professor Guy Young | 沈銘鏡 教授 |
| 10:15-10:25 | Q & A | ||
| 10:25-10:35 | Coffee Break | ||
| 會員演講一 | |||
| 10:35-10:50 | Moderna-Induced Immune Thrombotic Thrombocytopenia complicated with cerebral infarction and hemorrhage | 劉懿 醫師 三總 |
林東燦 教授 |
| 10:50-11:05 | Deep vein thrombosis among Taiwanese patients undergoing major orthopedic or colorectal cancer surgery in Taiwan: a prospective cross-sectional study | 林炫聿 醫師 彰基 |
|
| 11:05-11:20 | Characterization of congenital factor XII deficiency in Taiwanese patients — identification of one novel and one common mutation | 周聖傑 醫師 台大 |
|
| Lunch Symposiums 11:20-13:20(非台灣血栓暨止血學會之會員，午餐請自理) | |||
| 11:20-12:00 | Emicizumab Treatment For Hemophilia Patients with High titer Inhibitor Undergone Surgery: Cases Sharing | 陳宇欽 醫師 三總 |
彭慶添 教授 |
| 12:00-12:40 | Continuing the commitment to patients with Haemophilia A: Clinical evidence of N8-GP (turoctocog alfa pegol)( Novonordisk) | Professor Guy Young | 沈銘鏡 教授 |
| 12:40-13:20 | Reaching new heights in Hemophilia A: Success through personalized FVIII treatment (Bayer) | 王建得 醫師 中榮 |
沈銘鏡 教授 |
| 13:20-14:00 | Coffee Break | ||
| 特別演講 | |||
| 14:00-14:50 | Non-inversion genetic variation of factor VIII gene in sporadic hemophilia A originate mainly in female | 沈銘鏡 教授 | 彭慶添 教授 |
| 14:50-15:20 | 會員大會 | 彭慶添 理事長 / 林炫聿 秘書長 | |
| 15:20-15:50 | Coffee Break | ||
| 會員演講二 | |||
| 15:50-16:05 | Clinical features and genetic defect in 6 index patients with congenital fibrinogen disorders: 3 novel mutations with common mutation in Taiwan population | 王建得 醫師 中榮 |
徐會棋 教授 |
| 16:05-16:20 | Comparison of platelet function with different tyrosine kinase inhibitors treatment in chronic myeloid leukemia with major molecular remission, in vivo and ex vivo studies | 吳懿峰 醫師 慈濟 |
|
| 16:20-16:35 | Impact of Hemophilia Care in Taiwan | 翁德甫 醫師 中山附醫 |
邱世欣 教授 |
| 16:35-16:50 | VWF:activity/VWF:Ag ratio, but neither VWF level nor FVIII trough level, is a predictor for annualized bleeding rate in patients with severe hemophilia A on rFVIII-Fc prophylaxis therapy | 張家堯 醫師 北醫 附醫 |
|
| 16:50-17:00 | 閉幕致詞 | 沈銘鏡 榮譽理事長 | |
